IE 11 is a very old Browser and it`s not supported on this site

Consolidated statement of changes in equity for the year ended December 31

(in CHF 1 000)

 

 

Share capital

 

Treasury shares

 

Retained earnings

 

Total

Balances at January 1, 2019

 

11 080

 

 

2 873 432

 

2 884 512

Dividend

 

 

 

(168 970)

 

(168 970)

Total comprehensive income for the year

 

 

 

677 431

 

677 431

Balances at December 31, 2019

 

11 080

 

 

3 381 893

 

3 392 973

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances at January 1, 2020

 

11 080

 

 

3 381 893

 

3 392 973

Dividend

 

 

 

(188 360)

 

(188 360)

Trade with treasury shares (incl. change in balance)

 

 

(8 241)

 

1

 

(8 240)

Total comprehensive income for the year

 

 

 

691 174

 

691 174

Balances at December 31, 2020

 

11 080

 

(8 241)

 

3 884 708

 

3 887 547

The notes are an integral part of the consolidated financial statements.

BB Biotech AG uses cookies to improve website usability and ensure the best possible user experience.Use of cookies & disclaimer